The World Health Organization (WHO) today launched a global AWaRe campaign, which aims to support national health systems to make more judicious use of lifesaving drugs so as to combat a worldwide trend of antimicrobial resistance (AMR) – including increased pathogen resistance to common antibiotics, antivirals and anti-fungal medications. However, WHO’s own 2018 Report on […] Continue reading ->
Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading ->
In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading ->
Click here or on the image below to be redirected to the Knowledge Portal. Continue reading ->
A new Knowledge Portal that aims to ease policymakers’ access to reliable information about themes in medicines access, pricing and pharma innovation was launched today by the Global Health Centre of Geneva’s Graduate Institute of International and Development Studies. The Portal currently covers some 17 topics grouped under three broad themes – Pricing, Intellectual Property […] Continue reading ->
Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading ->
Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading ->
A medical doctor and epidemiologist, Dr Seth Berkley joined Gavi, the Vaccine Alliance, as its CEO in August 2011. Under his leadership, Gavi reached the milestone in 2015 of more than half a billion children vaccinated in the world’s 73 poorest countries. In the same year, Berkley led Gavi to its second successful replenishment, raising […] Continue reading ->
A major agreement has been signed between Gavi, the Vaccine Alliance, and two private sector partners to deploy a new form of biometric fingerprint technology to give children – who may not even have a birth certificate – a complete medical record in order to track critical childhood vaccines. Image Credits: Simprints, Simprints . Continue reading ->
After applauding the United States Congress for passing a bill that aims to strengthen preparedness against global disease threats, an R&D advocacy group is now calling on Congressional leaders to ensure there is actually money allocated to fund an expanded set of activities. Image Credits: PATH/Eric Becker. Continue reading ->